Hello不Kitty的个人主页 - 老虎社区

Hello不Kitty

Hello不Kitty

暂无个人介绍

IP属地：海外

127关注

1粉丝

7主题

0勋章

07-28

$Veritone Inc.(VERI)$ 回调到2.1附近再入手

07-17

$Veritone Inc.(VERI)$ 类似pltr，只是不具有针对性的调查，从混乱中寻找线索

07-17

$Veritone Inc.(VERI)$

07-11

fda都已经批了，日本，和加拿大市场都打开了看好

异动解读 | Kalvista Pharmaceuticals股价盘中大跌5.53%，2025财年净亏损扩大44%

07-11

$Wolfspeed Inc.(WOLF)$ 没有时间了，要尽快拉低吸筹，几大机构持仓已经大大超过散户，最近还会波动，直到散户离场，价格震荡上行。现在到9月，公司不会发布任何有利的消息，一切交给庄家🎉('ω')🎉

02-14

看好这个股票的潜力，调整仓位

异动解读 | Cellebrite季报业绩不佳股价盘中重挫近12%

2024-11-02

$爱奇艺(IQ)$ 2024年前三季度，全国规模以上文化企业营收99668亿元，同比增长5.9%。文化服务业收入53077亿元，增长7.6%。九大文化领域全面增长，其中文化装备生产增速最快达10%。文化新业态收入41616亿元，增长10%，对行业增长贡献率达68.2%。文化企业总利润7903亿元，增长3.9%。爱奇艺作为典型文创产业龙头公司，期望下个月财报有不错的表现

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3562560508203735","uuid":"3562560508203735","gmtCreate":1599475776552,"gmtModify":1730555365238,"name":"Hello不Kitty","pinyin":"hellobkittyhellobukitty","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":127,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":7,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":2,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.20","exceedPercentage":"80.07%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.15","exceedPercentage":"93.70%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"海外","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":66,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":461521339203592,"gmtCreate":1753694286536,"gmtModify":1753694287726,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"0\"></v-v> 回调到2.1附近再入手","listText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"0\"></v-v> 回调到2.1附近再入手","text":"$Veritone Inc.(VERI)$ 回调到2.1附近再入手","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/461521339203592","isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":457440595186464,"gmtCreate":1752716979864,"gmtModify":1752716981129,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"1\"></v-v> 类似pltr，只是不具有针对性的调查，从混乱中寻找线索","listText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"1\"></v-v> 类似pltr，只是不具有针对性的调查，从混乱中寻找线索","text":"$Veritone Inc.(VERI)$ 类似pltr，只是不具有针对性的调查，从混乱中寻找线索","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/457440595186464","isVote":1,"tweetType":1,"viewCount":347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":457439382708960,"gmtCreate":1752716900432,"gmtModify":1752716901095,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Veritone Inc.(VERI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/457439382708960","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":455506604474664,"gmtCreate":1752244796023,"gmtModify":1752247544075,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"fda都已经批了，日本，和加拿大市场都打开了&nbsp; 看好","listText":"fda都已经批了，日本，和加拿大市场都打开了&nbsp; 看好","text":"fda都已经批了，日本，和加拿大市场都打开了 看好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/455506604474664","repostId":"1100750260","repostType":4,"repost":{"id":"1100750260","kind":"news","weMediaInfo":{"introduction":"个股异动一手消息解读","home_visible":1,"media_name":"异动解读","id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1752240743,"share":"https://www.laohu8.com/m/news/1100750260?lang=&edition=full","pubTime":"2025-07-11 21:32","market":"hk","language":"zh","title":"异动解读 | Kalvista Pharmaceuticals股价盘中大跌5.53%，2025财年净亏损扩大44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100750260","media":"异动解读","summary":"7月11日周五，Kalvista Pharmaceuticals Inc股价在盘中大跌5.53%，引起市场关注。这一显著跌幅与公司最新发布的2025财年财报密切相关。根据Kalvista Pharmaceuticals公布的财报，公司2025财年净亏损达1.83亿美元，同比扩大44.09%。从资产负债状况来看，Kalvista Pharmaceuticals的财务状况同样不容乐观。公司总负债为1.55亿美元，资产负债比高达1.62，而流动比率仅为0.06，表明公司面临较大的财务压力和流动性风险。作为一家专注于开发小分子蛋白酶抑制剂的制药公司，Kalvista Pharmaceuticals的未来发展仍值得市场持续关注。","content":"<p>7月11日周五，Kalvista Pharmaceuticals Inc（股票代码：KALV）股价在盘中大跌5.53%，引起市场关注。这一显著跌幅与公司最新发布的2025财年财报密切相关。</p>\n\n<p>根据Kalvista Pharmaceuticals公布的财报，公司2025财年净亏损达1.83亿美元，同比扩大44.09%。更值得注意的是，公司报告期内营业收入为0美元，每股基本亏损3.69美元。这些数据显示公司面临严峻的财务挑战，可能是导致投资者信心下降的主要原因。</p>\n\n<p>从资产负债状况来看，Kalvista Pharmaceuticals的财务状况同样不容乐观。公司总负债为1.55亿美元，资产负债比高达1.62，而流动比率仅为0.06，表明公司面临较大的财务压力和流动性风险。尽管如此，分析机构对公司前景仍保持谨慎乐观，9家机构给出的平均目标价为30.89美元，最高目标价达40美元。作为一家专注于开发小分子蛋白酶抑制剂的制药公司，Kalvista Pharmaceuticals的未来发展仍值得市场持续关注。</p>","source":"ai_movement_cn","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | Kalvista Pharmaceuticals股价盘中大跌5.53%，2025财年净亏损扩大44%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | Kalvista Pharmaceuticals股价盘中大跌5.53%，2025财年净亏损扩大44%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2025-07-11 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月11日周五，Kalvista Pharmaceuticals Inc（股票代码：KALV）股价在盘中大跌5.53%，引起市场关注。这一显著跌幅与公司最新发布的2025财年财报密切相关。</p>\n\n<p>根据Kalvista Pharmaceuticals公布的财报，公司2025财年净亏损达1.83亿美元，同比扩大44.09%。更值得注意的是，公司报告期内营业收入为0美元，每股基本亏损3.69美元。这些数据显示公司面临严峻的财务挑战，可能是导致投资者信心下降的主要原因。</p>\n\n<p>从资产负债状况来看，Kalvista Pharmaceuticals的财务状况同样不容乐观。公司总负债为1.55亿美元，资产负债比高达1.62，而流动比率仅为0.06，表明公司面临较大的财务压力和流动性风险。尽管如此，分析机构对公司前景仍保持谨慎乐观，9家机构给出的平均目标价为30.89美元，最高目标价达40美元。作为一家专注于开发小分子蛋白酶抑制剂的制药公司，Kalvista Pharmaceuticals的未来发展仍值得市场持续关注。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KALV":"Kalvista Pharmaceuticals Inc"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100750260","content_text":"7月11日周五，Kalvista Pharmaceuticals Inc（股票代码：KALV）股价在盘中大跌5.53%，引起市场关注。这一显著跌幅与公司最新发布的2025财年财报密切相关。\n根据Kalvista Pharmaceuticals公布的财报，公司2025财年净亏损达1.83亿美元，同比扩大44.09%。更值得注意的是，公司报告期内营业收入为0美元，每股基本亏损3.69美元。这些数据显示公司面临严峻的财务挑战，可能是导致投资者信心下降的主要原因。\n从资产负债状况来看，Kalvista Pharmaceuticals的财务状况同样不容乐观。公司总负债为1.55亿美元，资产负债比高达1.62，而流动比率仅为0.06，表明公司面临较大的财务压力和流动性风险。尽管如此，分析机构对公司前景仍保持谨慎乐观，9家机构给出的平均目标价为30.89美元，最高目标价达40美元。作为一家专注于开发小分子蛋白酶抑制剂的制药公司，Kalvista Pharmaceuticals的未来发展仍值得市场持续关注。","news_type":1,"symbols_score_info":{"KALV":1}},"isVote":1,"tweetType":1,"viewCount":232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":455256760984040,"gmtCreate":1752183356107,"gmtModify":1752183915871,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WOLF\">$Wolfspeed Inc.(WOLF)$&nbsp;</a> 没有时间了，要尽快拉低吸筹，几大机构持仓已经大大超过散户，最近还会波动，直到散户离场，价格震荡上行。现在到9月，公司不会发布任何有利的消息，一切交给庄家🎉('ω')🎉","listText":"<a href=\"https://laohu8.com/S/WOLF\">$Wolfspeed Inc.(WOLF)$&nbsp;</a> 没有时间了，要尽快拉低吸筹，几大机构持仓已经大大超过散户，最近还会波动，直到散户离场，价格震荡上行。现在到9月，公司不会发布任何有利的消息，一切交给庄家🎉('ω')🎉","text":"$Wolfspeed Inc.(WOLF)$ 没有时间了，要尽快拉低吸筹，几大机构持仓已经大大超过散户，最近还会波动，直到散户离场，价格震荡上行。现在到9月，公司不会发布任何有利的消息，一切交给庄家🎉('ω')🎉","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/455256760984040","isVote":1,"tweetType":1,"viewCount":3229,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3548327979456421","authorId":"3548327979456421","name":"LXLG","avatar":"https://static.tigerbbs.com/62e3fc85037bbf95961fe255e5ee0718","crmLevel":6,"crmLevelSwitch":0,"idStr":"3548327979456421","authorIdStr":"3548327979456421"},"content":"听不懂，为啥要让散户离场呐","text":"听不懂，为啥要让散户离场呐","html":"听不懂，为啥要让散户离场呐"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":403309945016600,"gmtCreate":1739483119322,"gmtModify":1739483677087,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"看好这个 股票的潜力，调整仓位","listText":"看好这个 股票的潜力，调整仓位","text":"看好这个 股票的潜力，调整仓位","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/403309945016600","repostId":"1168950707","repostType":4,"repost":{"id":"1168950707","kind":"news","weMediaInfo":{"introduction":"个股异动一手消息解读","home_visible":1,"media_name":"异动解读","id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1739460097,"share":"https://www.laohu8.com/m/news/1168950707?lang=&edition=full","pubTime":"2025-02-13 23:21","market":"us","language":"zh","title":"异动解读 | Cellebrite季报业绩不佳股价盘中重挫近12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168950707","media":"异动解读","summary":"以色列数字情报公司Cellebrite股价今天盘中大跌11.63%,引发了市场的广泛关注。导致该股股价大跌的主要原因是该公司2024财年第四季度财报数据令投资者失望。财报显示,尽管该公司本季度销售额达到1.09亿美元,高于市场预期的1.07亿美元,同比增长17.19%,但其每股收益只有0.1美元,与去年同期的0.11美元相比有所下滑。分析人士表示,尽管营收实现了两位数增长,但净利润和每股收益的下滑显示了该公司的利润率可能正在承压。","content":"<p>以色列数字情报公司Cellebrite(NASDAQ:CLBT)股价今天盘中大跌11.63%,引发了市场的广泛关注。</p>\n\n<p>导致该股股价大跌的主要原因是该公司2024财年第四季度财报数据令投资者失望。财报显示,尽管该公司本季度销售额达到1.09亿美元,高于市场预期的1.07亿美元,同比增长17.19%,但其每股收益只有0.1美元,与去年同期的0.11美元相比有所下滑。</p>\n\n<p>分析人士表示,尽管营收实现了两位数增长,但净利润和每股收益的下滑显示了该公司的利润率可能正在承压。在人工智能和云计算等新兴技术领域,研发投入加大可能使其利润率正在受到冲击。投资者对该公司未来的盈利能力存在担忧,导致该股今日承压大跌。</p>","source":"ai_movement_cn","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | Cellebrite季报业绩不佳股价盘中重挫近12%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | Cellebrite季报业绩不佳股价盘中重挫近12%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2025-02-13 23:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>以色列数字情报公司Cellebrite(NASDAQ:CLBT)股价今天盘中大跌11.63%,引发了市场的广泛关注。</p>\n\n<p>导致该股股价大跌的主要原因是该公司2024财年第四季度财报数据令投资者失望。财报显示,尽管该公司本季度销售额达到1.09亿美元,高于市场预期的1.07亿美元,同比增长17.19%,但其每股收益只有0.1美元,与去年同期的0.11美元相比有所下滑。</p>\n\n<p>分析人士表示,尽管营收实现了两位数增长,但净利润和每股收益的下滑显示了该公司的利润率可能正在承压。在人工智能和云计算等新兴技术领域,研发投入加大可能使其利润率正在受到冲击。投资者对该公司未来的盈利能力存在担忧,导致该股今日承压大跌。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLBT":"Cellebrite"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168950707","content_text":"以色列数字情报公司Cellebrite(NASDAQ:CLBT)股价今天盘中大跌11.63%,引发了市场的广泛关注。\n导致该股股价大跌的主要原因是该公司2024财年第四季度财报数据令投资者失望。财报显示,尽管该公司本季度销售额达到1.09亿美元,高于市场预期的1.07亿美元,同比增长17.19%,但其每股收益只有0.1美元,与去年同期的0.11美元相比有所下滑。\n分析人士表示,尽管营收实现了两位数增长,但净利润和每股收益的下滑显示了该公司的利润率可能正在承压。在人工智能和云计算等新兴技术领域,研发投入加大可能使其利润率正在受到冲击。投资者对该公司未来的盈利能力存在担忧,导致该股今日承压大跌。","news_type":1,"symbols_score_info":{"CLBT":1}},"isVote":1,"tweetType":1,"viewCount":530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":366615955394832,"gmtCreate":1730547486687,"gmtModify":1730555301409,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IQ\">$爱奇艺(IQ)$&nbsp;</a><v-v data-views=\"1\"></v-v> 2024年前三季度，全国规模以上文化企业营收99668亿元，同比增长5.9%。文化服务业收入53077亿元，增长7.6%。九大文化领域全面增长，其中文化装备生产增速最快达10%。文化新业态收入41616亿元，增长10%，对行业增长贡献率达68.2%。文化企业总利润7903亿元，增长3.9%。爱奇艺作为典型文创产业龙头公司，期望下个月财报有不错的表现","listText":"<a href=\"https://laohu8.com/S/IQ\">$爱奇艺(IQ)$&nbsp;</a><v-v data-views=\"1\"></v-v> 2024年前三季度，全国规模以上文化企业营收99668亿元，同比增长5.9%。文化服务业收入53077亿元，增长7.6%。九大文化领域全面增长，其中文化装备生产增速最快达10%。文化新业态收入41616亿元，增长10%，对行业增长贡献率达68.2%。文化企业总利润7903亿元，增长3.9%。爱奇艺作为典型文创产业龙头公司，期望下个月财报有不错的表现","text":"$爱奇艺(IQ)$ 2024年前三季度，全国规模以上文化企业营收99668亿元，同比增长5.9%。文化服务业收入53077亿元，增长7.6%。九大文化领域全面增长，其中文化装备生产增速最快达10%。文化新业态收入41616亿元，增长10%，对行业增长贡献率达68.2%。文化企业总利润7903亿元，增长3.9%。爱奇艺作为典型文创产业龙头公司，期望下个月财报有不错的表现","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/366615955394832","isVote":1,"tweetType":1,"viewCount":2362,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578710894627072","authorId":"3578710894627072","name":"保平","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"idStr":"3578710894627072","authorIdStr":"3578710894627072"},"content":"自从买了就一直掉！咋了！想退市吗！","text":"自从买了就一直掉！咋了！想退市吗！","html":"自从买了就一直掉！咋了！想退市吗！"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":366615955394832,"gmtCreate":1730547486687,"gmtModify":1730555301409,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IQ\">$爱奇艺(IQ)$&nbsp;</a><v-v data-views=\"1\"></v-v> 2024年前三季度，全国规模以上文化企业营收99668亿元，同比增长5.9%。文化服务业收入53077亿元，增长7.6%。九大文化领域全面增长，其中文化装备生产增速最快达10%。文化新业态收入41616亿元，增长10%，对行业增长贡献率达68.2%。文化企业总利润7903亿元，增长3.9%。爱奇艺作为典型文创产业龙头公司，期望下个月财报有不错的表现","listText":"<a href=\"https://laohu8.com/S/IQ\">$爱奇艺(IQ)$&nbsp;</a><v-v data-views=\"1\"></v-v> 2024年前三季度，全国规模以上文化企业营收99668亿元，同比增长5.9%。文化服务业收入53077亿元，增长7.6%。九大文化领域全面增长，其中文化装备生产增速最快达10%。文化新业态收入41616亿元，增长10%，对行业增长贡献率达68.2%。文化企业总利润7903亿元，增长3.9%。爱奇艺作为典型文创产业龙头公司，期望下个月财报有不错的表现","text":"$爱奇艺(IQ)$ 2024年前三季度，全国规模以上文化企业营收99668亿元，同比增长5.9%。文化服务业收入53077亿元，增长7.6%。九大文化领域全面增长，其中文化装备生产增速最快达10%。文化新业态收入41616亿元，增长10%，对行业增长贡献率达68.2%。文化企业总利润7903亿元，增长3.9%。爱奇艺作为典型文创产业龙头公司，期望下个月财报有不错的表现","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/366615955394832","isVote":1,"tweetType":1,"viewCount":2362,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578710894627072","authorId":"3578710894627072","name":"保平","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"idStr":"3578710894627072","authorIdStr":"3578710894627072"},"content":"自从买了就一直掉！咋了！想退市吗！","text":"自从买了就一直掉！咋了！想退市吗！","html":"自从买了就一直掉！咋了！想退市吗！"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":455256760984040,"gmtCreate":1752183356107,"gmtModify":1752183915871,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WOLF\">$Wolfspeed Inc.(WOLF)$&nbsp;</a> 没有时间了，要尽快拉低吸筹，几大机构持仓已经大大超过散户，最近还会波动，直到散户离场，价格震荡上行。现在到9月，公司不会发布任何有利的消息，一切交给庄家🎉('ω')🎉","listText":"<a href=\"https://laohu8.com/S/WOLF\">$Wolfspeed Inc.(WOLF)$&nbsp;</a> 没有时间了，要尽快拉低吸筹，几大机构持仓已经大大超过散户，最近还会波动，直到散户离场，价格震荡上行。现在到9月，公司不会发布任何有利的消息，一切交给庄家🎉('ω')🎉","text":"$Wolfspeed Inc.(WOLF)$ 没有时间了，要尽快拉低吸筹，几大机构持仓已经大大超过散户，最近还会波动，直到散户离场，价格震荡上行。现在到9月，公司不会发布任何有利的消息，一切交给庄家🎉('ω')🎉","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/455256760984040","isVote":1,"tweetType":1,"viewCount":3229,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3548327979456421","authorId":"3548327979456421","name":"LXLG","avatar":"https://static.tigerbbs.com/62e3fc85037bbf95961fe255e5ee0718","crmLevel":6,"crmLevelSwitch":0,"idStr":"3548327979456421","authorIdStr":"3548327979456421"},"content":"听不懂，为啥要让散户离场呐","text":"听不懂，为啥要让散户离场呐","html":"听不懂，为啥要让散户离场呐"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":457440595186464,"gmtCreate":1752716979864,"gmtModify":1752716981129,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"1\"></v-v> 类似pltr，只是不具有针对性的调查，从混乱中寻找线索","listText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"1\"></v-v> 类似pltr，只是不具有针对性的调查，从混乱中寻找线索","text":"$Veritone Inc.(VERI)$ 类似pltr，只是不具有针对性的调查，从混乱中寻找线索","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/457440595186464","isVote":1,"tweetType":1,"viewCount":347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":461521339203592,"gmtCreate":1753694286536,"gmtModify":1753694287726,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"0\"></v-v> 回调到2.1附近再入手","listText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"0\"></v-v> 回调到2.1附近再入手","text":"$Veritone Inc.(VERI)$ 回调到2.1附近再入手","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/461521339203592","isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":457439382708960,"gmtCreate":1752716900432,"gmtModify":1752716901095,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://laohu8.com/S/VERI\">$Veritone Inc.(VERI)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Veritone Inc.(VERI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/457439382708960","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":455506604474664,"gmtCreate":1752244796023,"gmtModify":1752247544075,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"fda都已经批了，日本，和加拿大市场都打开了&nbsp; 看好","listText":"fda都已经批了，日本，和加拿大市场都打开了&nbsp; 看好","text":"fda都已经批了，日本，和加拿大市场都打开了 看好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/455506604474664","repostId":"1100750260","repostType":4,"repost":{"id":"1100750260","kind":"news","weMediaInfo":{"introduction":"个股异动一手消息解读","home_visible":1,"media_name":"异动解读","id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1752240743,"share":"https://www.laohu8.com/m/news/1100750260?lang=&edition=full","pubTime":"2025-07-11 21:32","market":"hk","language":"zh","title":"异动解读 | Kalvista Pharmaceuticals股价盘中大跌5.53%，2025财年净亏损扩大44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100750260","media":"异动解读","summary":"7月11日周五，Kalvista Pharmaceuticals Inc股价在盘中大跌5.53%，引起市场关注。这一显著跌幅与公司最新发布的2025财年财报密切相关。根据Kalvista Pharmaceuticals公布的财报，公司2025财年净亏损达1.83亿美元，同比扩大44.09%。从资产负债状况来看，Kalvista Pharmaceuticals的财务状况同样不容乐观。公司总负债为1.55亿美元，资产负债比高达1.62，而流动比率仅为0.06，表明公司面临较大的财务压力和流动性风险。作为一家专注于开发小分子蛋白酶抑制剂的制药公司，Kalvista Pharmaceuticals的未来发展仍值得市场持续关注。","content":"<p>7月11日周五，Kalvista Pharmaceuticals Inc（股票代码：KALV）股价在盘中大跌5.53%，引起市场关注。这一显著跌幅与公司最新发布的2025财年财报密切相关。</p>\n\n<p>根据Kalvista Pharmaceuticals公布的财报，公司2025财年净亏损达1.83亿美元，同比扩大44.09%。更值得注意的是，公司报告期内营业收入为0美元，每股基本亏损3.69美元。这些数据显示公司面临严峻的财务挑战，可能是导致投资者信心下降的主要原因。</p>\n\n<p>从资产负债状况来看，Kalvista Pharmaceuticals的财务状况同样不容乐观。公司总负债为1.55亿美元，资产负债比高达1.62，而流动比率仅为0.06，表明公司面临较大的财务压力和流动性风险。尽管如此，分析机构对公司前景仍保持谨慎乐观，9家机构给出的平均目标价为30.89美元，最高目标价达40美元。作为一家专注于开发小分子蛋白酶抑制剂的制药公司，Kalvista Pharmaceuticals的未来发展仍值得市场持续关注。</p>","source":"ai_movement_cn","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | Kalvista Pharmaceuticals股价盘中大跌5.53%，2025财年净亏损扩大44%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | Kalvista Pharmaceuticals股价盘中大跌5.53%，2025财年净亏损扩大44%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2025-07-11 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月11日周五，Kalvista Pharmaceuticals Inc（股票代码：KALV）股价在盘中大跌5.53%，引起市场关注。这一显著跌幅与公司最新发布的2025财年财报密切相关。</p>\n\n<p>根据Kalvista Pharmaceuticals公布的财报，公司2025财年净亏损达1.83亿美元，同比扩大44.09%。更值得注意的是，公司报告期内营业收入为0美元，每股基本亏损3.69美元。这些数据显示公司面临严峻的财务挑战，可能是导致投资者信心下降的主要原因。</p>\n\n<p>从资产负债状况来看，Kalvista Pharmaceuticals的财务状况同样不容乐观。公司总负债为1.55亿美元，资产负债比高达1.62，而流动比率仅为0.06，表明公司面临较大的财务压力和流动性风险。尽管如此，分析机构对公司前景仍保持谨慎乐观，9家机构给出的平均目标价为30.89美元，最高目标价达40美元。作为一家专注于开发小分子蛋白酶抑制剂的制药公司，Kalvista Pharmaceuticals的未来发展仍值得市场持续关注。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KALV":"Kalvista Pharmaceuticals Inc"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100750260","content_text":"7月11日周五，Kalvista Pharmaceuticals Inc（股票代码：KALV）股价在盘中大跌5.53%，引起市场关注。这一显著跌幅与公司最新发布的2025财年财报密切相关。\n根据Kalvista Pharmaceuticals公布的财报，公司2025财年净亏损达1.83亿美元，同比扩大44.09%。更值得注意的是，公司报告期内营业收入为0美元，每股基本亏损3.69美元。这些数据显示公司面临严峻的财务挑战，可能是导致投资者信心下降的主要原因。\n从资产负债状况来看，Kalvista Pharmaceuticals的财务状况同样不容乐观。公司总负债为1.55亿美元，资产负债比高达1.62，而流动比率仅为0.06，表明公司面临较大的财务压力和流动性风险。尽管如此，分析机构对公司前景仍保持谨慎乐观，9家机构给出的平均目标价为30.89美元，最高目标价达40美元。作为一家专注于开发小分子蛋白酶抑制剂的制药公司，Kalvista Pharmaceuticals的未来发展仍值得市场持续关注。","news_type":1,"symbols_score_info":{"KALV":1}},"isVote":1,"tweetType":1,"viewCount":232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":403309945016600,"gmtCreate":1739483119322,"gmtModify":1739483677087,"author":{"id":"3562560508203735","authorId":"3562560508203735","name":"Hello不Kitty","avatar":"https://static.tigerbbs.com/a89ace00d7c99ac8f39dea94b04dbbe8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562560508203735","authorIdStr":"3562560508203735"},"themes":[],"htmlText":"看好这个 股票的潜力，调整仓位","listText":"看好这个 股票的潜力，调整仓位","text":"看好这个 股票的潜力，调整仓位","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/403309945016600","repostId":"1168950707","repostType":4,"repost":{"id":"1168950707","kind":"news","weMediaInfo":{"introduction":"个股异动一手消息解读","home_visible":1,"media_name":"异动解读","id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1739460097,"share":"https://www.laohu8.com/m/news/1168950707?lang=&edition=full","pubTime":"2025-02-13 23:21","market":"us","language":"zh","title":"异动解读 | Cellebrite季报业绩不佳股价盘中重挫近12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168950707","media":"异动解读","summary":"以色列数字情报公司Cellebrite股价今天盘中大跌11.63%,引发了市场的广泛关注。导致该股股价大跌的主要原因是该公司2024财年第四季度财报数据令投资者失望。财报显示,尽管该公司本季度销售额达到1.09亿美元,高于市场预期的1.07亿美元,同比增长17.19%,但其每股收益只有0.1美元,与去年同期的0.11美元相比有所下滑。分析人士表示,尽管营收实现了两位数增长,但净利润和每股收益的下滑显示了该公司的利润率可能正在承压。","content":"<p>以色列数字情报公司Cellebrite(NASDAQ:CLBT)股价今天盘中大跌11.63%,引发了市场的广泛关注。</p>\n\n<p>导致该股股价大跌的主要原因是该公司2024财年第四季度财报数据令投资者失望。财报显示,尽管该公司本季度销售额达到1.09亿美元,高于市场预期的1.07亿美元,同比增长17.19%,但其每股收益只有0.1美元,与去年同期的0.11美元相比有所下滑。</p>\n\n<p>分析人士表示,尽管营收实现了两位数增长,但净利润和每股收益的下滑显示了该公司的利润率可能正在承压。在人工智能和云计算等新兴技术领域,研发投入加大可能使其利润率正在受到冲击。投资者对该公司未来的盈利能力存在担忧,导致该股今日承压大跌。</p>","source":"ai_movement_cn","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | Cellebrite季报业绩不佳股价盘中重挫近12%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | Cellebrite季报业绩不佳股价盘中重挫近12%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2025-02-13 23:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>以色列数字情报公司Cellebrite(NASDAQ:CLBT)股价今天盘中大跌11.63%,引发了市场的广泛关注。</p>\n\n<p>导致该股股价大跌的主要原因是该公司2024财年第四季度财报数据令投资者失望。财报显示,尽管该公司本季度销售额达到1.09亿美元,高于市场预期的1.07亿美元,同比增长17.19%,但其每股收益只有0.1美元,与去年同期的0.11美元相比有所下滑。</p>\n\n<p>分析人士表示,尽管营收实现了两位数增长,但净利润和每股收益的下滑显示了该公司的利润率可能正在承压。在人工智能和云计算等新兴技术领域,研发投入加大可能使其利润率正在受到冲击。投资者对该公司未来的盈利能力存在担忧,导致该股今日承压大跌。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLBT":"Cellebrite"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168950707","content_text":"以色列数字情报公司Cellebrite(NASDAQ:CLBT)股价今天盘中大跌11.63%,引发了市场的广泛关注。\n导致该股股价大跌的主要原因是该公司2024财年第四季度财报数据令投资者失望。财报显示,尽管该公司本季度销售额达到1.09亿美元,高于市场预期的1.07亿美元,同比增长17.19%,但其每股收益只有0.1美元,与去年同期的0.11美元相比有所下滑。\n分析人士表示,尽管营收实现了两位数增长,但净利润和每股收益的下滑显示了该公司的利润率可能正在承压。在人工智能和云计算等新兴技术领域,研发投入加大可能使其利润率正在受到冲击。投资者对该公司未来的盈利能力存在担忧,导致该股今日承压大跌。","news_type":1,"symbols_score_info":{"CLBT":1}},"isVote":1,"tweetType":1,"viewCount":530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}